After adjusting for age, sex and other coexisting conditions, the researchers found patients with naturally high levels of hemoglobin did not have an increased risk of death, compared to those with lower hemoglobin levels or with those taking medications to maintain hemoglobin levels higher than 12 g/dL. The study appears Dec. 16 in the Journal of the American Society of Nephrology.